Literature DB >> 3335053

Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons.

S F Vatner1, T A Patrick, D R Knight, W T Manders, J T Fallon.   

Abstract

Two groups of chronically instrumented, conscious baboons were studied. The effects of coronary artery occlusion for 3 hours and reperfusion for 1 week were examined on measurements of left ventricular function, ischemic-zone wall thickness, regional myocardial blood flow, arrhythmias, and extent of necrosis. The experimental group of animals (n = 7) was treated with the calcium channel blocker nisoldipine (0.1 microgram/kg/min) from 1 hour after coronary occlusion to 3 hours after coronary reperfusion. The control group (n = 6) received the vehicle (n = 4) or saline (n = 2). The effects of coronary artery occlusion and reperfusion on arterial pressure, left ventricular systolic pressure, heart rate, and left ventricular dP/dt were similar in both groups. Systolic wall thickening was reversed to paradoxical wall thinning during occlusion in both groups, and there was no recovery to systolic wall thickening over the 1-week period in either group. There were differences in regional blood flow; during coronary artery occlusion, nisoldipine increased blood flow significantly in the endocardium and epicardium of nonischemic and ischemic zones. There was a major difference in the number of arrhythmic beats per minute on reperfusion; during reperfusion, the number of arrhythmias rose markedly in the vehicle-treated group but actually fell in the nisoldipine-treated group. The size of areas at risk, infarcts, infarcts related to the area at risk, and amount of total creatine kinase (CK) and MB-CK appearing in blood were not significantly different in the two groups. Thus, in the conscious baboon, nisoldipine administered 1 hour after coronary artery occlusion exerted a marked effect in diminishing reperfusion-induced arrhythmias and improved blood flow to the ischemic zone during occlusion but did not salvage ischemic tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335053     DOI: 10.1161/01.res.62.1.105

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

1.  Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism.

Authors:  R Weidenbach; R Schulz; P Gres; M Behrends; H Post; G Heusch
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Effects on infarct size of reperfusion and pretreatment with beta-blockade and calcium antagonists.

Authors:  S Torr; A J Drake-Holland; M Main; J Hynd; K Isted; M I Noble
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

Review 3.  Why So Few New Cardiovascular Drugs Translate to the Clinics.

Authors:  Stephen F Vatner
Journal:  Circ Res       Date:  2016-09-02       Impact factor: 17.367

Review 4.  Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention.

Authors:  L H Opie; W A Coetzee
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

5.  Effect of amlodipine on myocardial functional and metabolic recovery following coronary occlusion and reperfusion in dogs.

Authors:  G J Gross; N E Farber; G M Pieper
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 6.  Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

7.  R56865 is antifibrillatory in reperfused ischemic guinea-pig hearts, even when given only during reperfusion.

Authors:  E Scheufler; A Mozes; I Guttmann; B Wilffert
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

8.  Reperfusion-induced arrhythmias and myocardial ion shifts: a pharmacologic interaction between pinacidil and cicletanine in isolated rat hearts.

Authors:  A Tosaki; P Szerdahelyi; D K Das
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.